Skip to main content
Fig. 1 | Molecular Cancer

Fig. 1

From: DC - SIGNR by influencing the lncRNA HNRNPKP2 upregulates the expression of CXCR4 in gastric cancer liver metastasis

Fig. 1

The level of DC-SIGNR in gastric cancer patients and its clinical significance. a, the level of DC-SIGNR in gastric cancer patients serum (n = 207) compared with healthy group (n = 197). DC-SIGNR level was examined by ELISA. b, examination of the correlation between DC-SIGNR level and advanced pathological stage. c, DC-SIGNR in healthy group (n = 197); patients with no metastasis (n = 151), liver metastasis (n = 43), or lung, ovary and colon metastasis (n = 17)

Back to article page

Molecular Cancer

ISSN: 1476-4598